Activation of extracellular signal-regulated kinase in human prostate cancer.

[1]  H. Frierson,et al.  Activation of mitogen-activated protein kinase associated with prostate cancer progression. , 1999, Cancer research.

[2]  R. Lefkowitz,et al.  Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. , 1998, Science.

[3]  K. Meier,et al.  Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC‐3 human prostate cancer cells , 1998, Journal of cellular physiology.

[4]  J. Neary.  MAPK CASCADES IN CELL GROWTH AND DEATH , 1997 .

[5]  G. Nuovo,et al.  Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.

[6]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[7]  W. Rayford,et al.  Muscarinic cholinergic receptors promote growth of human prostate cancer cells , 1997, The Prostate.

[8]  I. Leav,et al.  Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate. , 1996, Carcinogenesis.

[9]  M. Loda,et al.  Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[10]  S. Magnuson,et al.  Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. , 1996, Cancer research.

[11]  M. Kawaichi,et al.  Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.

[12]  M. Steiner,et al.  Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. , 1995, The Journal of urology.

[13]  A. Brunet,et al.  Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.

[14]  C. Logothetis,et al.  Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. , 1993, The Journal of urology.

[15]  D. Peehl.  Oncogenes in prostate cancer. An update , 1993, Cancer.

[16]  M. Ciomei,et al.  Bombesin stimulates growth of human prostatic cancer cells in vitro , 1990, Cancer.

[17]  M. Loda,et al.  Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[18]  A. Brunet,et al.  [MAP kinase module: role in the control of cell proliferation]. , 1995, Comptes rendus des seances de la Societe de biologie et de ses filiales.

[19]  I. Leav,et al.  Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats. , 1993, Laboratory investigation; a journal of technical methods and pathology.